AMGEN INC 10-Q filing
Filed 2025-08-06 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000318154-25-000056
- Form type
- 10-Q
- CIK
- 0000318154
- Primary document
- https://www.sec.gov/Archives/edgar/data/318154/000031815425000056/amgn-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AMGEN INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $17.3B | - | - |
| Cost Of Revenue | $6.0B | - | - |
| Operating Income | $3.8B | - | - |
| Net Income | $3.2B | - | - |
| Eps Basic | 5.88 | - | - |
| Eps Diluted | 5.84 | - | - |
| Cash And Equivalents | $8.0B | - | - |
| Total Assets | $87.9B | - | - |
| Shareholders Equity | $7.4B | - | - |
| Operating Cash Flow | $3.7B | - | - |
| Capital Expenditures | $780.0M | - | - |